Navigation Links
Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
Date:10/6/2009

SAN DIEGO, Oct. 6 /PRNewswire/ -- Amira Pharmaceuticals, Inc., a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease, announced today that Robert Baltera, Chief Executive Officer, will present a company overview at the Montgomery Healthcare Conference 2009 in Menlo Park, Calif., today.

About Amira

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. Its scientific founders have successfully worked together for more than a decade and were pivotal in the discovery of a number of inflammatory drugs, including Singulair®. The drug hunters at Amira are now actively leveraging their history of success to create high-value compounds for the future. For more information, visit www.amirapharm.com.

SOURCE Amira Pharmaceuticals, Inc.


'/>"/>
SOURCE Amira Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
2. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
3. Amira Pharmaceuticals to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
4. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
5. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
6. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
7. Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors
8. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
9. Amira Pharmaceuticals Appoints First Vice President of Development
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... New York, NY (PRWEB) August 29, 2014 ... industry experienced sparse revenue growth over the ... instability. During the recession, consumers had less disposable ... from grocery stores and visited restaurants less frequently. ... fast food establishments declined, hindering revenue growth. “After ...
(Date:8/29/2014)... 2014 ReputationChief.Com, a well-established online reputation ... Bad Reviews’. This service has been launched to help ... negative reviews against them. , In order to make ... the committed results to its clients, ReputationChief.Com has designed ... of internet marketing. , As per the indications from ...
(Date:8/29/2014)... 2014 Last week, the Fed reported ... monthly gain. Industrial production rose to 0.4% while manufacturing output ... is the single largest boost since February this year. Capacity ... since February as well – an increase that could be ... to a 79.2% rate, which is a measure of slack ...
(Date:8/29/2014)... CPR and basic life support (BLS) videos available ... recent health guidelines, according to a new study ... journal for the Australasian College for Emergency Medicine ... sudden cardiac arrest are known to improve survival ... specialists put together the study, which reviewed educational ...
(Date:8/29/2014)... 29, 2014 As a chiropractic physician ... understands that there’s a direct connection between the condition ... and back. "Since conventional shoe inserts and orthotics weren’t ... of my own," he said. , Customizable to a ... support for the foot in order to help prevent ...
Breaking Medicine News(10 mins):Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:ReputationChief.Com Announces a New Service ‘Remove Bad Reviews’ 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3
... time how our brain,s response changes the closer a ... a volunteer is pursued by an artificial predator, the ... strategic areas of the brain towards more reactive responses ... a threat, such as a large bear, humans, like ...
... In the eyes of mammals, visual information is processed on a ... brain, according to a new report in the August 24 issue ... found in mice that the eyes normal rhythmic response to light ... ticking. The retina is a layer of nerve tissue covering the ...
... in the technology that will drive next generation computers and ... which produces a state that appears to be both on ... simultaneously on and off are vital for the next-generation super ... bits, that are either on or off. , Previously, ...
... study finds , , THURSDAY, Aug. 23 (HealthDay News) -- After ... pre-diabetes rises steeply, a new study finds. , In fact, ... likely to develop diabetes compared with the general population and ... sugar, according to the report in the Aug. 25 issue ...
... reading actually respond better to female teachers, according to ... higher positive self-perceptions as readers when they worked with ... assistants. , The study focused on 175 third- and ... their teachers. The boys participated in a 10-week reading ...
... and bad, experts say , , THURSDAY, Aug. 23 (HealthDay News) ... something, a new study may explain why. , Scientists say ... while a totally separate area is in charge of ... region, involved in an aspect of self-control, may change conceptions ...
Cached Medicine News:Health News:Free will takes flight: how our brains respond to an approaching menace 2Health News:Mouse vision has a rhythm all its own 2Health News:Heart Attack Boosts Diabetes Risk 2Health News:Scientists Spot Brain's 'Free Will' Center 2Health News:Scientists Spot Brain's 'Free Will' Center 3
(Date:8/29/2014)... VANCOUVER, British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" ... 2014 fiscal year-end financial statements.  The Company recently changed ... to facilitate an application to list its common stock ... possible. DelMar,s financial statements as filed with ...
(Date:8/29/2014)... , Aug. 29, 2014 ... PHG AEX: PHIA) ... European Society of Cardiology (ESC) Congress ... highlighting the full range of its cardiology solutions serving clinicians ... from prevention and diagnosis, to ...
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... discover technological and commercial prospects What does ... market? Visiongain,s brand new report shows you ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
Designed to minimize emblolic debris in SVGs and carotids...
... therapy extends the ability of interventional ... coronary artery disease, and provides non-interventional ... in the treatment of patients who ... EECP therapy provides a noninvasive, atraumatic ...
... The dual lumen petite titanium ... mm catheter (each lumen) and ... oval lumen catheters offer larger ... catheter strength. Dual lumen offset-tip ...
... The dual lumen M.R.I. model ... 1.2 mm inner diameter catheters ... catheters offer larger lumen equivalency ... ,Dual lumen offset-tip catheters are ...
Medicine Products: